02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Pruritus<br />

(1997): Golsch S+, Hautarzt 48, 249<br />

Mucosal<br />

Xerostomia<br />

(1997): Med Lett <strong>Drug</strong>s Ther 39, 107<br />

Hair<br />

Hair – alopecia<br />

(2001): Parker V+, Can J Psychiatry 46(1), 77<br />

Other<br />

Hepatotoxicity<br />

(2006): Teschke R, Dtsch Med Wochenschr 131(34-3), 1880 (with<br />

Kava)<br />

Hypersensitivity<br />

Side effects (sic)<br />

(1999): Tinsley JA, Minn Med 82(5), 29<br />

Note: St John’s wort is a natural source of flavoring in Europe.<br />

Although not indigenous to Australia, <strong>and</strong> long considered a weed, St<br />

John’s wort is now grown there as a cash crop <strong>and</strong> produces 20% of<br />

the world’s supply<br />

STANOZOLOL<br />

Trade names: Menabol; Stromba; Winstrol (Ovation)<br />

Indications: Hereditary angioedema<br />

Category: Anabolic steroid<br />

Half-life: N/A<br />

Clinically important, potentially hazardous interactions<br />

with: anticoagulants, warfarin<br />

Reactions<br />

Skin<br />

Acne (>10%)<br />

(1995): Helfman T+, JAmAcadDermatol32, 254<br />

Edema<br />

Exanthems<br />

Folliculitis<br />

(1995): Helfman T+, JAmAcadDermatol32, 254<br />

Pigmentation (1–10%)<br />

Rosacea<br />

(1995): Helfman T+, JAmAcadDermatol32, 254<br />

Seborrheic dermatitis<br />

(1995): Helfman T+, JAmAcadDermatol32, 254<br />

Urticaria<br />

Hair<br />

Hair – alopecia (in women)<br />

Hair – hirsutism (in women)<br />

(1995): Helfman T+, JAmAcadDermatol32, 254<br />

(1987): Sheffer AL+, J Allergy Clin Immunol 80, 855<br />

Other<br />

Chills (1–10%)<br />

Death<br />

(2001): Fineschi V+, Arch Pathol Lab Med 125(2), 253 (abuse)<br />

(1999): Sullivan ML+, J Emerg Med 17(5), 851 (abuse)<br />

Gynecomastia (>10%)<br />

(1995): Helfman T+, JAmAcadDermatol32, 254<br />

Hepatotoxicity<br />

(2002): Stimac D+, J Clin Gastroenterol 35(4), 350 (abuse)<br />

(2000): Segal S+, JAmAcadDermatol43(3), 558<br />

Hypersensitivity<br />

Nephrotoxicity<br />

(1999): Habscheid W+, Dtsch Med Wochenschr 124(36), 1029<br />

(1994): Yoshida EM+, CMAJ 151(6), 791 (abuse)<br />

STAR ANISE (Chinese)<br />

Scientific name: Illicium verum<br />

Family: Illiciaceae<br />

Trade <strong>and</strong> other common names: Anisi stellati fructus;<br />

Badiana; Chinese anise; Eight-horned anise<br />

Category: Antimycobacterial; Insecticide<br />

Purported indications <strong>and</strong> other uses: Bronchitis, colic,<br />

cough, flatulence, menstrual complaints, respiratory tract<br />

inflammation. Culinary spice, fragrance component in cosmetics<br />

Half-life: N/A<br />

Note: Star anise preparations are sometimes contaminated with<br />

highly poisonous Japanese star anise (Illicium anisatum)<br />

Star anise contains a compound used in the manufacture of Tamiflu<br />

Skin<br />

Dermatitis<br />

Erythema<br />

Scaling<br />

Sensitization<br />

STAVUDINE<br />

Reactions<br />

Synonym: d4T<br />

Trade name: Zerit (Bristol-Myers Squibb)<br />

Indications: Human immunodeficiency virus (HIV)<br />

Category: Antiretroviral; Nucleoside analog reverse<br />

transcriptase inhibitor<br />

Half-life: 1.44 hours<br />

Reactions<br />

STAVUDINE 505<br />

Skin<br />

Allergic reactions (sic) (9%)<br />

Diaphoresis (19%)<br />

Neutrophilic eccrine hidradenitis<br />

(1998): Krischer J+, JDermatol25, 199<br />

Rash (sic) (~40%)<br />

Other<br />

Chills (50%)<br />

Death<br />

(2001): Hwang SW+, Singapore Med J 42(6), 247 (2 cases) (with<br />

didanosine)<br />

Gynecomastia<br />

(2001): Aquilina C+, IntJSTDAIDS12(7), 481 (with didanosine)<br />

(2001): Manfredi R+, Ann Pharmacother 35(4), 438 (with<br />

didanosine)<br />

(2001): Manfredi R+, Ann Pharmacother 35(4), 438 (with<br />

lamivudine) (3 cases)<br />

(1998): Melbourne KM+, Ann Pharmacother 32, 1108<br />

Lipoatrophy<br />

(2004): McComsey GA+, Clin Infect Dis 38(2), 263<br />

(2001): Lichtenstein KA+, AIDS 15(11), 1389<br />

Lipodystrophy<br />

(2002): Bernasconi E+, J Acquir Immune Defic Syndr 31(1), 50<br />

(2002): Reid S, Can Adv <strong>Drug</strong> Reaction Newsletter 12, 5<br />

(2001): Aquilina C+, IntJSTDAIDS12(7), 481 (with didanosine)<br />

(2001): Arpadi SM+, J Acquir Immune Defic Syndr 27(1), 30<br />

(2001): Bogner JR+, J Acquir Immune Defic Syndr 27(3), 237<br />

(2001): van der Valk M+, AIDS 15(7), 847<br />

(1999): Ruel M+, Ann Med Interne (Paris) (French) 150, 269

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!